The European Medicines Agency has recommended the use of the modern vaccine of the company “Moderna” for children aged 12 to 17 years.
According to the EMA, the method of administration will be the same as for the 18-year-old age group, two doses with 4 weeks difference from each other.
According to experts, “modern” vaccination creates immunity against coronavirus in children from 12 to 17 years old, similar to what it causes in young people from 18 to 25 years old.
So far, the pfizer / biontech vaccine has been the only option for vaccinating children in Europe.
